tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

PCKAILE Stock Latest News

Kailera Therapeutics Highlights Positive Phase 2 Data for Oral Obesity Therapy
Private CompaniesKailera Therapeutics Highlights Positive Phase 2 Data for Oral Obesity Therapy
15d ago
KAILE
Kailera Advances Global Ribupatide Obesity Franchise on Strong Oral Phase 2 Data
PremiumPrivate Companies
Kailera Advances Global Ribupatide Obesity Franchise on Strong Oral Phase 2 Data
16d ago
KAILE
Kailera Therapeutics Expands Clinical Data Management to Support Growing Metabolic Disease Pipeline
PremiumPrivate Companies
Kailera Therapeutics Expands Clinical Data Management to Support Growing Metabolic Disease Pipeline
23d ago
KAILE
Kailera Therapeutics Highlights Mission-Driven Culture in Obesity Treatment Focus
PremiumPrivate Companies
Kailera Therapeutics Highlights Mission-Driven Culture in Obesity Treatment Focus
1M ago
KAILE
Kailera Therapeutics CEO Highlights Obesity Pipeline at World Economic Forum in Davos
PremiumPrivate Companies
Kailera Therapeutics CEO Highlights Obesity Pipeline at World Economic Forum in Davos
1M ago
KAILE
Kailera Therapeutics Launches Phase 3 Obesity Program for Ribupatide and Highlights Hengrui Partnership at JPM 2026
PremiumPrivate CompaniesKailera Therapeutics Launches Phase 3 Obesity Program for Ribupatide and Highlights Hengrui Partnership at JPM 2026
1M ago
KAILE
Kailera Therapeutics – Weekly Recap
Premium
Private Companies
Kailera Therapeutics – Weekly Recap
1M ago
KAILE
Kailera Therapeutics Advances Obesity Candidate Ribupatide Into Global Phase 3 Trial
Premium
Private Companies
Kailera Therapeutics Advances Obesity Candidate Ribupatide Into Global Phase 3 Trial
1M ago
KAILE
Kailera Therapeutics Launches Global Phase 3 Program for Ribupatide in Obesity
PremiumPrivate Companies
Kailera Therapeutics Launches Global Phase 3 Program for Ribupatide in Obesity
1M ago
KAILE
Kailera Therapeutics Names Veteran Biopharma Finance Executive Doug Pagán as CFO to Support Phase 3 Obesity Pipeline
PremiumPrivate Companies
Kailera Therapeutics Names Veteran Biopharma Finance Executive Doug Pagán as CFO to Support Phase 3 Obesity Pipeline
2M ago
KAILE
Kailera Therapeutics CEO to Present Obesity Pipeline Strategy at J.P. Morgan Healthcare Conference
PremiumPrivate Companies
Kailera Therapeutics CEO to Present Obesity Pipeline Strategy at J.P. Morgan Healthcare Conference
2M ago
KAILE
Kailera Therapeutics Advances Global Phase 3 Trials for Obesity Treatment
PremiumPrivate Companies
Kailera Therapeutics Advances Global Phase 3 Trials for Obesity Treatment
4M ago
KAILE
Kailera Therapeutics Strengthens Board with Strategic Appointment
PremiumPrivate CompaniesKailera Therapeutics Strengthens Board with Strategic Appointment
4M ago
KAILE

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >